Rheumatoid Arthritis Posts - Page 21 of 35 on Medivizor
Navigation Menu

Rheumatoid Arthritis Posts on Medivizor

The use of reminders and adherence to treatment plans for rheumatoid arthritis

The use of reminders and adherence to treatment plans for rheumatoid arthritis

Posted by on Oct 27, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study looked at the characteristics of rheumatoid arthritis patients who were more likely to use reminders to adhere to their treatment plan and the effect this had on disease activity. The authors concluded that older white men were most likely to use medical reminders. The use of calendar reminders was associated with fewer tender...

Read More

The benefits of injectable methotrexate compared to oral solutions for rheumatoid arthritis

Posted by on Oct 18, 2016 in Rheumatoid Arthritis | 4 comments

In a nutshell This study looked at the benefits of switching from an oral dose of methotrexate (Rheumatrex) to a subcutaneous (under the skin) injection. The authors concluded that the benefits of subcutaneous methotrexate include improved effectiveness at higher doses and few side effects. Some background Patients with rheumatoid arthritis (RA)...

Read More

Comparing treatment options for rheumatoid arthritis unresponsive to anti-TNF drugs

Posted by on Oct 7, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study compared the effectiveness of different biological drugs in patients with rheumatoid arthritis who have already been unresponsive to anti-tumor necrosis factor (TNF) treatment. The authors concluded that a non-TNF biological treatment was more effective at lowering disease activity than taking a second anti-TNF...

Read More

Can inflammation in rheumatoid arthritis patients lead to chronic kidney disease?

Can inflammation in rheumatoid arthritis patients lead to chronic kidney disease?

Posted by on Sep 12, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study looked at the effect of inflammation on the development of chronic kidney disease in patients with rheumatoid arthritis. The authors concluded that patients with persistent inflammation are at a higher risk of developing chronic kidney disease.  Some background Patients with rheumatoid arthritis (RA) most often...

Read More

Are non-steroidal anti-inflammatory drugs associated with small intestinal injury?

Are non-steroidal anti-inflammatory drugs associated with small intestinal injury?

Posted by on Sep 5, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study assessed the association between non-steroidal anti-inflammatory drugs (NSAIDs) and small intestinal injury in patients with rheumatoid arthritis and osteoarthritis. The authors concluded that there was a higher rate of small intestinal injury in patients treated with NSAIDs. Some background Patients with rheumatoid...

Read More

Does tocilizumab treatment aggravate lung disease in patients with rheumatoid arthritis?

Does tocilizumab treatment aggravate lung disease in patients with rheumatoid arthritis?

Posted by on Aug 15, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study looked at the risk of interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA) during tocilizumab (Actemra) treatment. The authors concluded that patients over 60, smokers, or patients not responding well to tocilizumab treatment are at greater risk of developing ILD. Some background Interstitial lung...

Read More

Does leflunomide treatment increase the risk of lung disease in rheumatoid arthritis?

Does leflunomide treatment increase the risk of lung disease in rheumatoid arthritis?

Posted by on Aug 10, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell The aim of this study was to examine the link between leflunomide (Arava) treatment and lung disease in patients with rheumatoid arthritis. The authors concluded that leflunomide was not associated with increased likelihood of lung disease. Some background Patients with rheumatoid arthritis (RA) often experience...

Read More

Does tocilizumab lead to intestinal perforation in patients with rheumatoid arthritis?

Does tocilizumab lead to intestinal perforation in patients with rheumatoid arthritis?

Posted by on Aug 7, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study looked at the risk of developing lower intestinal perforations (tears) in patients with rheumatoid arthritis treated with tocilizumab (Actemra). The authors concluded that tocilizumab treatment increases the risk of lower intestinal perforations compared to other treatments. Some background One problem encountered by some...

Read More